Exacerbation of dipeptidyl peptidase‐ IV inhibitor‐associated bullous pemphigoid by the immune checkpoint inhibitors durvalumab and tremelimumab
Year: 2025
Type: article
Source: The Journal of Dermatology
Institutions: Hokkaido University, Steel Memorial Muroran Hospital
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407591663
